Teleflex Receives FDA Clearance for the ARROW® Triple Lumen Pressure Injectable Acute Hemodialysis Catheter
03 September 2015 - 9:30PM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies for critical care and surgery, has announced
it has received FDA 510(k) clearance to market its ARROW® Triple
Lumen Pressure Injectable Acute Hemodialysis Catheter.
“To support our goal of providing the right line for the right
patient at the right time, adding the ARROW® Triple Lumen Pressure
Injectable Acute Hemodialysis Catheter to our hemodialysis
portfolio provides options to clinicians when choosing the best
catheter for their patient,” states Jay White, President, Vascular
Division of Teleflex.
The ARROW® Triple Lumen Pressure Injectable Acute Hemodialysis
Catheter is available in the ARROW® ErgoPack® System, helping
hospitals maintain compliance with current vascular access
guidelines and standards while providing maximal barrier protection
against infections when inserting these lines. Teleflex is
committed to partnering with healthcare facilities to reduce
vascular access related complications. The ARROW® Triple Lumen
Pressure Injectable Acute Hemodialysis Catheter is another example
of the Teleflex commitment to this goal.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA,
Pilling, Rusch, Weck and ErgoPack are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates, in the U.S.
and/or other countries.
© 2015 Teleflex Incorporated. All rights reserved. MC-001588
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150903005155/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2024 to May 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From May 2023 to May 2024